Tampons Are in Short Supply Across United States
WEDNESDAY, June 22, 2022 (HealthDay News) -- Women aren't imagining it as they view near-empty store shelves: Global supply chain issues have prompted a shortage of tampons.
Reports on social media of shortages were confirmed this week by the on-demand grocery delivery service, Instacart, as searches for tampons rose 13% over last week.
At the same time, the ability of Instacart's shoppers to fill orders dropped 67%, the lowest since the pandemic began, CNN Business reported. Moreover, shoppers looking to hoard tampons have sent sales up 29% week over week.
"We're beginning to see tampon turbulence show up in the Instacart app in response to the growing shortage, with purchasing behavior beginning to rival that of the beginning of the pandemic, as customers adopt stock-up behavior," Laurentia Romaniuk, Instacart's trend expert and senior product manager, said in a statement.
Shortages are being caused by supply problems getting cotton and plastic, which have been in high demand from the start of the pandemic because they are used to make personal protective equipment (PPE). The war in the Ukraine has also exacerbated the shortage, as Russia and Ukraine are major exporters of fertilizer used to grow cotton. Meanwhile, a Texas drought has also made things worse for cotton crops.
Procter & Gamble, which owns Tampax and the Always brand, told CNN Business that the Tampax team is "producing tampons 24/7 to meet the increased demand."
"We understand it is frustrating for consumers when they can't find what they need," a company spokesperson said. "We can assure you this is a temporary situation."
Walgreens and CVS are aware of shortages of tampons and other women's health products and are working to restock as soon as possible, CNN Business reported.
More information
Visit CNET for more on the tampon shortage.
SOURCE: CNN Business
Related Posts
Use of Specialized Infant Formula for Cow’s Milk Allergy Rising
THURSDAY, July 7, 2022 (HealthDay News) -- In the early 21st century,...
SARS-CoV-2 Vaccination Seems Safe After MIS-C
THURSDAY, March 31, 2022 (HealthDay News) -- Severe acute respiratory syndrome...
¿COVID o gripe? La FDA aprueba la primera prueba a domicilio para ambas
LUNES, 27 de febrero de 2023 (HealthDay News) -- Una nueva prueba a domicilio...
La FDA aprueba la primera pastilla para tratar la enfermedad de Crohn de moderada a grave
VIERNES, 19 de mayo de 2023 (HealthDay News) -- Los pacientes con enfermedad de...